Bausch Health, formerly known as Valeant Pharmaceuticals, reduced its debt further, paying down an additional $100 million in senior secured term loans through cash flow.
After making this payment, Bausch has paid off all mandatory amortizations through the second quarter of 2020.
Bausch Health CEO Joseph Papa has taken several steps to pay down the company's debt since joining the company in May 2016.
More articles on surgery centers:
Managing anesthesia services in ASCs — 5 top problems + solutions
5 questions to ask ASC anesthesia providers
CRH Medical acquires Florida gastroenterology anesthesia practice — 3 insights